SEARCH
Toggle navigation
HOME
COMPANY
TECHNOLOGY
IMMUNOBODY
MODITOPE
AVIDIMAB
COVIDITY
SCIENTIFIC PAPERS & POSTERS
PRODUCTS
PRODUCT PIPELINE
SCIB1
SCIB2
Modi-1
Modi-2
INVESTORS
COMPANY PROFILE
ADVISORS
CORPORATE GOVERNANCE
DOCUMENTS & PRESENTATIONS
SHARE INFO
FINANCIAL INFO
2020 CAPITAL RAISE
REGULATORY NEWS
REGULATORY NEWS ARCHIVE
NEWS
LATEST NEWS
INTERVIEWS
MEDIA COVERAGE
WEBCASTS
YEAR - 2020
YEAR - 2019
YEAR - 2018
YEAR - 2017
YEAR - 2016
YEAR - 2015
CONTACT US
SEARCH
INVESTORS
DOCUMENTS & PRESENTATIONS
HOME
COMPANY
TECHNOLOGY
IMMUNOBODY
MODITOPE
AVIDIMAB
COVIDITY
SCIENTIFIC PAPERS & POSTERS
PRODUCTS
PRODUCT PIPELINE
SCIB1
SCIB2
Modi-1
Modi-2
INVESTORS
COMPANY PROFILE
ADVISORS
CORPORATE GOVERNANCE
DOCUMENTS & PRESENTATIONS
SHARE INFO
FINANCIAL INFO
2020 CAPITAL RAISE
REGULATORY NEWS
REGULATORY NEWS ARCHIVE
NEWS
LATEST NEWS
INTERVIEWS
MEDIA COVERAGE
WEBCASTS
YEAR - 2020
YEAR - 2019
YEAR - 2018
YEAR - 2017
YEAR - 2016
YEAR - 2015
CONTACT US
Documents & Presentations
Annual General Meeting
Notice of Annual General Meeting November 2020
Notice of Annual General Meeting September 2019
Notice of Annual General Meeting October 2018
Notice of Annual General Meeting October 2017
Notice of Annual General Meeting October 2016
Notice of Annual General Meeting October 2015
Presentations
Proactive Investors Presentation, 27th August 2020 (video link)
Scancell Presentation to LSX World Congress February 2020
AGM Presentation 2019
Shares Magazine Investor Presentation July 2019 (video link)
Shares Magazine Investor Presentation July 2019
Scancell Proactive Investors Presentation April 2019
Scancell China BioCentury Presentation November 2018
Scancell LSX Presentation November 2018
Scancell Proactive Investors Presentation November 2018
AGM Presentation 2018
Scancell Presentation February 2018
AGM Presentation 2017
AGM Presentation 2016
Trinity Delta Reports
Redmile funding releases the brakes 17 November 2020
Material fund raise means clinical progress in sight
COVID 2nd generation vaccine opportunity is all upside May 2020
Reasons to be cheerful May 2020
Interim results show encouraging progress January 2020
A sweet source of financing September 2019
SCIB1 Phase II study starts in UK August 2019
Ground prepared for an important period July 2019
Vulpes investment brings £3.88m in new funds June 2019
SCIB2 to use new nanoparticle formulation May 2019
Phase II melanoma study with SCIB1 to start in Q219 April 2019
Interim results show progress being maintained January 2019
Missing out on CRUK Grand Challenge January 2019
Opening new pathways in immuno-oncology November 2018
Hardman & Co Reports
View February 2018 Report
View September 2016 Report
Circulars
Scancell Circular 23rd July 2020
Scancell Circular 19th April 2018
Scancell Circular 11th March 2016
Scancell Circular 9th July 2013
Scancell Circular 30th June 2011
Memorandum of Association
Memorandum of Association
Certificate of incorporation
Certification of incorporation
Current Articles of Association
Current Articles of Association
Admission Document
Admission Document